New study pits elagolix against birth control pills for endometriosis pain relief
NCT ID NCT07532876
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares two treatments—elagolix and oral contraceptive pills (OCPs)—to see which better reduces pelvic pain from endometriosis. About 90 women aged 18-45 with confirmed endometriosis will report their pain levels over 24 weeks. The goal is to help doctors choose the best option for each patient.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ENDOMETRIOSIS (DIAGNOSIS) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Pak Emirates Military Hospital
Rawalpindi, Punjab Province, Pakistan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New imaging tracer could spot hidden cancers and fibrosis in one scan
- Saliva test for endometriosis: will it improve Women's lives?
- Ultrasound may spot endometriosis without surgery
- New ultrasound technique could end the need for surgery to diagnose endometriosis
- New supplement trial aims to ease endometriosis pain without drugs
- TENS device study for endometriosis pain withdrawn before start